Phase 1 Clinical Trials

Browse Phase 1 clinical trials. AI-powered analysis of Phase 1 studies with plain English summaries and decoded eligibility.

St. Jude Autologous Genome Edited Stem Cells For Sickle Cell Disease-1

NCT06506461 · RECRUITING · Phase 1 · St. Jude Children's Research Hospital

A Phase 1a/1b Open-Label Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of BBO-10203 in Subjects With Advanced Solid Tumors (The BREAKER-101 Study)

NCT06625775 · RECRUITING · Phase 1 · TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)

A Phase 1a, Open-Label, First-in-Human Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of KT501 by a Single Subcutaneous Administration in Participants With Rheumatoid Arthritis

NCT07234773 · RECRUITING · Phase 1 · Kali Therapeutics, Inc.

DAREON™-9: A Phase Ib Open-label Dose Escalation and Dose Confirmation Safety Study of Intravenous BI 764532 in Combination With a Single Agent Chemotherapy for the Treatment of Patients With Relapsed/Refractory Small Cell Lung Cancer After Platinum-based Chemotherapy

NCT05990738 · ACTIVE NOT RECRUITING · Phase 1 · Boehringer Ingelheim

Phase I Trial of Low-Dose Cyclophosphamide in Combination With Veliparib (ABT-888) in HER2/Neu-Negative Metastatic Breast Cancer

NCT01351909 · ACTIVE NOT RECRUITING · Phase 1 · National Cancer Institute (NCI)

Other Phases